331 related articles for article (PubMed ID: 25581251)
1. Association between health-related quality of life and symptoms in patients with chronic constipation: an integrated analysis of three phase 3 trials of prucalopride.
Tack J; Camilleri M; Dubois D; Vandeplassche L; Joseph A; Kerstens R
Neurogastroenterol Motil; 2015 Mar; 27(3):397-405. PubMed ID: 25581251
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled trial of prucalopride for severe chronic constipation.
Camilleri M; Kerstens R; Rykx A; Vandeplassche L
N Engl J Med; 2008 May; 358(22):2344-54. PubMed ID: 18509121
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy, safety, and tolerability of prucalopride in men with chronic constipation.
Yiannakou Y; Piessevaux H; Bouchoucha M; Schiefke I; Filip R; Gabalec L; Dina I; Stephenson D; Kerstens R; Etherson K; Levine A
Am J Gastroenterol; 2015 May; 110(5):741-8. PubMed ID: 25869393
[TBL] [Abstract][Full Text] [Related]
4. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.
Dubois D; Gilet H; Viala-Danten M; Tack J
Neurogastroenterol Motil; 2010 Feb; 22(2):e54-63. PubMed ID: 19761492
[TBL] [Abstract][Full Text] [Related]
5. Effect of prucalopride on symptoms of chronic constipation.
Tack J; Stanghellini V; Dubois D; Joseph A; Vandeplassche L; Kerstens R
Neurogastroenterol Motil; 2014 Jan; 26(1):21-7. PubMed ID: 24106924
[TBL] [Abstract][Full Text] [Related]
6. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation--a 12-week, randomized, double-blind, placebo-controlled study.
Quigley EM; Vandeplassche L; Kerstens R; Ausma J
Aliment Pharmacol Ther; 2009 Feb; 29(3):315-28. PubMed ID: 19035970
[TBL] [Abstract][Full Text] [Related]
7. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives.
Tack J; van Outryve M; Beyens G; Kerstens R; Vandeplassche L
Gut; 2009 Mar; 58(3):357-65. PubMed ID: 18987031
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: highly selective 5-HT4 agonists (prucalopride, velusetrag or naronapride) in chronic constipation.
Shin A; Camilleri M; Kolar G; Erwin P; West CP; Murad MH
Aliment Pharmacol Ther; 2014 Feb; 39(3):239-53. PubMed ID: 24308797
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A
Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103
[TBL] [Abstract][Full Text] [Related]
10. Prucalopride for the treatment of women with chronic constipation in whom standard laxative regimens have failed to provide adequate relief.
Pennant M; Orlando R; Barton P; Bayliss S; Routh K; Meads C
Health Technol Assess; 2011 May; 15 Suppl 1():43-50. PubMed ID: 21609652
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.
Camilleri M; Piessevaux H; Yiannakou Y; Tack J; Kerstens R; Quigley EMM; Ke M; Da Silva S; Levine A
Dig Dis Sci; 2016 Aug; 61(8):2357-2372. PubMed ID: 27056037
[TBL] [Abstract][Full Text] [Related]
12. Prucalopride: a review of its use in the management of chronic constipation.
Keating GM
Drugs; 2013 Nov; 73(17):1935-50. PubMed ID: 24194435
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of prucalopride in patients with chronic noncancer pain suffering from opioid-induced constipation.
Sloots CE; Rykx A; Cools M; Kerstens R; De Pauw M
Dig Dis Sci; 2010 Oct; 55(10):2912-21. PubMed ID: 20428949
[TBL] [Abstract][Full Text] [Related]
14. Prucalopride improves bowel function and colonic transit time in patients with chronic constipation: an integrated analysis.
Emmanuel A; Cools M; Vandeplassche L; Kerstens R
Am J Gastroenterol; 2014 Jun; 109(6):887-94. PubMed ID: 24732867
[TBL] [Abstract][Full Text] [Related]
15. Prucalopride is no more effective than placebo for children with functional constipation.
Mugie SM; Korczowski B; Bodi P; Green A; Kerstens R; Ausma J; Ruth M; Levine A; Benninga MA
Gastroenterology; 2014 Dec; 147(6):1285-95.e1. PubMed ID: 25239590
[TBL] [Abstract][Full Text] [Related]
16. Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment.
Cinca R; Chera D; Gruss HJ; Halphen M
Aliment Pharmacol Ther; 2013 May; 37(9):876-86. PubMed ID: 23480216
[TBL] [Abstract][Full Text] [Related]
17. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
[TBL] [Abstract][Full Text] [Related]
18. Prucalopride: A Review in Chronic Idiopathic Constipation.
Garnock-Jones KP
Drugs; 2016 Jan; 76(1):99-110. PubMed ID: 26628294
[TBL] [Abstract][Full Text] [Related]
19. Prucalopride in Gastroparesis: A Randomized Placebo-Controlled Crossover Study.
Carbone F; Van den Houte K; Clevers E; Andrews CN; Papathanasopoulos A; Holvoet L; Van Oudenhove L; Caenepeel P; Arts J; Vanuytsel T; Tack J
Am J Gastroenterol; 2019 Aug; 114(8):1265-1274. PubMed ID: 31295161
[TBL] [Abstract][Full Text] [Related]
20. [Some practical questions on chronic stipsis treatment with prucalopride].
Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
